-
The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for COVID. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.
-
Drug manufacturers invested in Russia’s pharmaceutical industry contend international humanitarian law requires they continue manufacturing and selling their products there, even while condemning the Ukraine invasion.
-
About 200 people are expected to be enrolled in the UF Health component of the trial, with about 15,000 participating nationwide
-
Pfizer studied a lower dose of its vaccine in more than 2,200 kindergartners and elementary school-aged kids. They developed coronavirus-fighting antibody levels as strong as teens and young adults.
-
When a new drug is up for FDA approval, trials may be held not only in the U.S. but other countries too. A study looks at global availability after approval. Big Pharma disagrees with the findings.
-
Parents who have enrolled their children in these studies say the risk is worth it for the greater good.
-
A rheumatologist in Miami-Dade seeks volunteers for a double-blind, placebo-controlled pilot study to test a drug that would treat COVID-19 long-hauler syndrome.
-
The global search for COVID-19 vaccines has included South Florida as drug companies use clinical research firms to find, manage, and follow local volunteers.
-
More than 50 VA medical centers are involved in trials to test vaccines and treatments for COVID-19, and the agency is calling on vets to volunteer.
-
Coronavirus vaccines could arrive in Florida within weeks. On "Florida Roundup," two journalists with ties to the state talk about what it’s like to participate in the clinical trials to develop the vaccines.